BPA Call 36C25921A0001-36C25921N0009

Award Date 10/1/20
Potential Completion Date 9/30/21
Potential Value $41K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Aurora, CO 80045, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $443,440.90 firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 19 to MdxHealth, Inc., a for-profit organization. The BPA is for the provision of proprietary genetic testing services in support of patient diagnosis, particularly for cancer, under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The contract does...
This is a Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 19 to MdxHealth, Inc. The contract, which has a ceiling value of $224,050.51, is for medical laboratory testing and analysis services to support the VISN 19 healthcare network. Specifically, the contract is for the fourth option year of a multi-year agreement to provide cancer testing and diagnostic services, including prostate, lung, and...
The Department of Veterans Affairs Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) call to Mdxhealth, Inc., a for-profit healthcare company, to provide Oncotype Prostate Cancer Testing services. The BPA is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract (FSS-621-II). The award has a potential value of $27,657.57 and a completion date of April 2, 2025. Mdxhealth has previously provided cancer testing services to the VA,...
This is a $826,186.14 Firm Fixed Price Blanket Purchase Agreement (BPA) Call awarded to Mdxhealth, Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide prostate cancer testing services. The contract is placed against the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS) contract. Mdxhealth, a for-profit healthcare company specializing in cancer diagnostics, will deliver these services to the VA's Veterans Integrated...
This is a Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 17 (VISN 17), a regional network within the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. The contract is for the provision of Oncotype DX genomic prostate cancer testing services to the Big Spring VA Medical Center. The award, which has a firm fixed price and a ceiling value of $9,696.96, is made under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule...
This is a Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) for Oncotype Prostate testing services. The prime contractor is Mdxhealth, Inc., a healthcare company that provides specialized cancer diagnostic testing. The $204,347.52 fixed-price contract was awarded on May 1, 2023 and has an ultimate completion date of April 30, 2024. It was issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. This contract...
This is a Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network (VISN) 17, a regional network of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. The award is for the company's MDXHEALTH GPS molecular diagnostic services, which provide cancer testing and analysis to support personalized treatment for veterans. The BPA call has a ceiling value of $15,964.65 and a period of performance through June 2025. This award is not set aside for a...
This is a delivery order awarded by the Veterans Integrated Service Network 21 (VISN 21), a regional network of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc., a for-profit healthcare company. The $1,132,338.36 firm-fixed-price contract is for Oncotype DX GPS (Genomic Prostate Score) testing services to be performed at the Mather, CA location. This order is issued under Mdxhealth's existing Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services....
This federal contract award, valued at $151,131.00, was made by the Veterans Integrated Service Network (VISN) 8, a division of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. The contract is for the provision of prostate cancer testing services, which will be delivered through a Blanket Purchase Agreement (BPA) under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule. Mdxhealth, a multinational healthcare company specializing in cancer...
This $319,293 firm-fixed-price federal contract was awarded by the Veterans Integrated Service Network (VISN) 17, a division of the U.S. Department of Veterans Affairs (VA), to Mdxhealth, Inc. for the provision of Oncotype DX prostate cancer testing services. The contract was issued as a Blanket Purchase Agreement (BPA) call order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract, which allows the VA to procure these specialized diagnostic testing...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by Veterans Integrated Service Network (VISN) 19 to MdxHealth, Inc. to provide genetic prostate cancer testing services. The $41,422.20 contract is a delivery order under MdxHealth's existing General Services Administration (GSA) Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services. MdxHealth, a for-profit healthcare company, will provide prostate cancer diagnostic testing to VISN 19, which covers Colorado and surrounding states. This BPA call falls under a larger $500,000 BPA awarded by VISN 19 to MdxHealth in 2020 for cancer testing services over a 5-year period. The contract is not set aside for any socioeconomic categories.

Generated 9/12/24, 11:49 AM